These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4129562)

  • 21. Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: objective and subjective response rates; duration and quality of life.
    Moore FD; VanDevanter SB; Boyden CM; Lokich J; Wilson RE
    Surgery; 1974 Sep; 76(3):376-90. PubMed ID: 4136510
    [No Abstract]   [Full Text] [Related]  

  • 22. Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion.
    SEGALOFF A; WEETH JB; RONGONE EL; MURISON PJ; BOWERS CY
    Cancer; 1960; 13():1017-20. PubMed ID: 13749676
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of the therapy combined with oophorectomy for the advanced breast cancer].
    Shinoda M; Oka T
    Gan No Rinsho; 1971; 17(9):670-5. PubMed ID: 5165861
    [No Abstract]   [Full Text] [Related]  

  • 24. [THE HORMONAL TREATMENT OF ADVANCED BREAST CANCER. STUDY METHODS: COMPARISON OF DELTA-1-TESTOLOLACTONE WITH TESTOSTERONE PROPIONATE].
    VANRYMENANT M; COUNE A; TAGNON HJ; SIMON S
    Acta Clin Belg; 1963; 18():469-79. PubMed ID: 14110611
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo effects of delta 1-testololactone on peripheral aromatization.
    Judd HL; Barone RM; Laufer LR; Gambone JC; Monfort SL; Lasley BL
    Cancer Res; 1982 Aug; 42(8 Suppl):3345s-3348s. PubMed ID: 7083208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
    Merke DP; Keil MF; Jones JV; Fields J; Hill S; Cutler GB
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1114-20. PubMed ID: 10720048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Which hormone therapy should be used in advanced breast carcinoma in males?].
    Lönning PE; Wiedemann G; Kvinnsland S; Lundgren S
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1358-61. PubMed ID: 2970379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoma of the male breast: a reappraisal.
    Ege G
    J Can Assoc Radiol; 1968 Dec; 19(4):195-9. PubMed ID: 4178236
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy in the treatment of advanced breast cancer.
    Russell IS; Moon WJ
    Med J Aust; 1977 Aug; 2(9):294-6. PubMed ID: 72343
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic castration for advanced breast cancer.
    Lee YT
    Am J Surg; 1971 Jul; 122(1):42-9. PubMed ID: 5091853
    [No Abstract]   [Full Text] [Related]  

  • 31. Tamoxifen in the palliative treatment of advanced breast cancer. A clinical review.
    Orr JD; Macdonald JA; Thomson JW
    J R Coll Surg Edinb; 1979 May; 24(3):141-7. PubMed ID: 88517
    [No Abstract]   [Full Text] [Related]  

  • 32. Calusterone (7beta,17alpha-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer.
    Gordan GS; Halden A; Horn Y; Fuery JJ; Parsons RJ; Walter RM
    Oncology; 1973; 28(2):138-46. PubMed ID: 4583006
    [No Abstract]   [Full Text] [Related]  

  • 33. A dose-response evaluation of androgens in the treatment of metastatic breast cancer.
    Talley RW; Haines CR; Waters MN; Goldenberg IS; Olson KB; Bisel HF
    Cancer; 1973 Aug; 32(2):315-20. PubMed ID: 4579091
    [No Abstract]   [Full Text] [Related]  

  • 34. [HORMONE TREATMENT OF BREAST CANCER IN THE ADVANCED PHASE. COMPARISON BETWEEN TESTOSTERONE PROPIONATE AND THE TESTOSTERONE-DELTA-1-TESTOLOLACTONE COMBINATION].
    ROYER P; DELAITRE R; MATHIEU H; GABILAN JC; RAYNAUD C; PASQUALINI JR; DEBRIS P; GERBEAUX S; HABIB R
    Rev Fr Etud Clin Biol; 1964 Jan; 9():88-90. PubMed ID: 14129164
    [No Abstract]   [Full Text] [Related]  

  • 35. Hormone treatment of breast cancer.
    Segaloff A
    JAMA; 1975 Dec; 234(11):1175-7. PubMed ID: 1242442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between vasopressin and corticosteroids in the palliative treatment of advanced breast cancer.
    Bernard-Weil E; Pilleron JP
    Oncology; 1973; 28(6):492-508. PubMed ID: 4129456
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bilateral ovaro-adrenalectomy in the treatment of inoperable breast carcinoma (clinical contribution)].
    Marinaccio G; Leggio A; Paccione F; Janora A
    G Ital Chir; 1965 May; 21(3):317-57. PubMed ID: 4159837
    [No Abstract]   [Full Text] [Related]  

  • 38. Current concepts in the treatment of advanced breast cancer.
    Gardner B
    Oncology; 1972; 26(2):188-96. PubMed ID: 4115086
    [No Abstract]   [Full Text] [Related]  

  • 39. Calusterone for breast cancer.
    Med Lett Drugs Ther; 1973 Nov; 15(23):95. PubMed ID: 4746413
    [No Abstract]   [Full Text] [Related]  

  • 40. [Proceedings: Histological findings of the ovary in breast carcinoma].
    Kofler E; Kolb R; Kratochwil A
    Arch Gynakol; 1973 Sep; 214(1):297-9. PubMed ID: 4801463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.